Volume 1, Issue 3 (2005) | American Journal of Infectious Diseases

Septicemia: The Principal Killer of Burns Patients

B. R. Sharma — 2010-09-30

American Journal of Infectious Diseases, Published online: 30 September 2010; doi:10.3844/ajidsp.2005.132.138

Burn injury is a major problem in many areas of the world and it has been estimated that 75% of all deaths following burns are related to infection. Burns impair the skin’s normal barrier function t...

Forensic Considerations of HIV Infected and Those at Risk

B. R. Sharma — 2005-09-30

American Journal of Infectious Diseases, Published online: 30 September 2005; doi:10.3844/ajidsp.2005.139.144

While HIV infection is considered protected information in most parts of the world, it is clear that if a health care provider knows, that the patient is infected or is likely to be infected, then eit...

Ciprofloxacin Does Not Exert Nephrotoxicity in Rats

Asli Baykal — 2005-09-30

American Journal of Infectious Diseases, Published online: 30 September 2005; doi:10.3844/ajidsp.2005.145.148

Ciprofloxacin, a member of the fluoroquinolone class, is an antibiotic used as a treatment for infections including the Anthrax bacteria. Studies concerning the safety and efficacy of ciprofloxacin ha...

Pharmacodynamic Comparison of the Carbapenems Against E. coli and Klebsiella spp. Containing Extended spectrum β-lactamases

Kathryn J. Eagye — 2005-09-30

American Journal of Infectious Diseases, Published online: 30 September 2005; doi:10.3844/ajidsp.2005.149.155

Carbapenems are the treatment of choice for extended-spectrum β-lactamases (ESBLs). Ertapenem is a new member of the carbapenem class, and is often grouped with imipenem and meropenem as a recommende...